Trials / Completed
CompletedNCT00083421
Effects of ONO-2506PO in Patients With Alzheimer's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 647 (actual)
- Sponsor
- Ono Pharma USA Inc · Industry
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-2506PO |
Timeline
- Start date
- 2004-06-01
- Completion
- 2007-07-01
- First posted
- 2004-06-18
- Last updated
- 2012-06-13
Locations
87 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00083421. Inclusion in this directory is not an endorsement.